XML 14 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Cash flows from operating activities      
Net loss $ (174,298) $ (78,779)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 411 269  
Stock-based compensation 11,725 14,301  
Issuance of PIK interest debt 1,707 1,772  
Accrued interest on revenue interest financing liability 24,173 10,550  
Amortization of debt discount 974 769  
Inventory reserve 243 0  
Other 2,971 1,157  
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets (2,303) (3,633)  
Accounts receivable, net (9,240) 0  
Accounts payable and accrued expenses 3,675 (8,447)  
Accrued interest 279 73  
Operating right-of-use assets and lease liabilities 90 99  
Inventory (148) 0  
Net cash used in operating activities (139,741) (61,869)  
Cash flows from investing activities      
Cash paid for property and equipment (86) (220)  
Net cash used in investing activities (86) (220)  
Cash flows from financing activities      
Proceeds from issuance of common stock from exercise of stock options 21 111  
Net proceeds from issuance of debt 34,650 0  
Net proceeds from underwritten public offering 0 141,390  
Net proceeds from issuance of common stock   14,073  
Net cash provided by financing activities 34,671 155,574  
Net (decrease) increase in cash and cash equivalents and restricted cash (105,156) 93,485  
Cash and cash equivalents and restricted cash - beginning of period 384,256 155,890 $ 155,890
Cash and cash equivalents and restricted cash - end of period 279,100 249,375 384,256
Supplemental disclosure of cash flow information      
Interest paid 7,819 5,310  
Supplemental disclosure of noncash investing and financing activities      
Property and equipment purchases included in accounts payable and accrued expenses 10 0  
Final interest payment fee 750 0  
Settlement of ESPP liability in common stock 770 856  
Settlement of 401(k) liability in common stock 712 $ 456  
At-the-Market Offering Program      
Cash flows from financing activities      
Net proceeds from issuance of common stock $ 0   $ 14,100